Press Releases
Matrix Medical Network Achieves Highest Level of Credentialing and Re-Credentialing from NCQA
Matrix Medical Network Achieves Highest Level of Credentialing and Re-Credentialing from NCQA
SCOTTSDALE, Ariz., May 9, 2023 – Matrix Medical Network (Matrix), a clinical leader in supporting the needs of at-risk populations, has achieved the highest level for credentialing and re-credentialing from the National Committee for Quality Assurance (NCQA). Most notably, Matrix achieved a 100 percent score across various rigorous assessments of its processes. As a result, Matrix received the much-coveted three-year accreditation, which is effective through August 2026. This accomplishment allows Matrix health plan clients to continue to fully delegate their credentialing responsibilities to Matrix. Additionally, it eliminates their need to provide credentialing oversight for the Matrix nurse practitioners who care for their members.
“Achieving NCQA recertification is a significant achievement for Matrix. It validates that our credentialing processes meet or exceed the industry’s highest quality standards.” said Catherine J. Tabaka, Matrix CEO. “The NCQA seal is widely recognized and accepted across the industry. It gives our health plan partners confidence in the services we provide to their members and confirms our unwavering commitment to excellence in everything we do.”
Credentialing and re-credentialing is an essential safety component of the healthcare system that is required by The Centers for Medicare and Medicaid Services (CMS). Matrix reviews and verifies every clinician’s training, experience, practice history, and license. This process, known as credentialing, is completed initially when a clinician is hired, and then at regular intervals thereafter. NCQA’s Credentialing/Re-credentialing program evaluates organizations that help health plans ensure providers have proper credentials.
Partnering with a clinical services organization that can ensure the availability of credentialed clinicians is vital to protecting entire populations from acute and chronic issues, while also reducing costs and legal exposure. Matrix has an established network of clinicians across the country and credentials just under 200 clinicians each month. As a part of the ongoing certification process, NCQA will audit Matrix triennially. NCQA’s Credentialing Accreditation focuses on consumer protection and customer service improvement, providing a framework for organizations to implement industry best practices that help them accurately and efficiently credential and re-credential healthcare professionals.
NCQA is a private, non-profit organization dedicated to improving healthcare quality. NCQA accredits and certifies a wide range of healthcare organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in healthcare. NCQA’s website (ncqa.org) contains information to help consumers, employers, and others make more informed healthcare choices.
About Matrix Medical Network
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live for more than 20 years. The organization’s network of approximately 4,000 clinicians meets individuals wherever they are to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Matrix Announces Sale of Laboratory Service Line to Karrington Clinical Laboratory
Matrix Announces Sale of Laboratory Service Line to Karrington Clinical Laboratory
SCOTTSDALE, Ariz. and FULTON, Md., Jan. 4, 2023 — Matrix Medical Network® (Matrix) and Karrington Clinical Laboratory, LLC (Karrington) today announced the sale of the Matrix Clinical Laboratory to Karrington, an organization with medical leadership and highly complex laboratory testing experience spanning more than two decades. The transition of ownership of the laboratory is a part of the overall strategy Matrix announced in 2022 to refocus its portfolio of services on in-home health and care assessments.
The transaction will provide Karrington an established CLIA-certified and CAP-accredited laboratory dedicated to delivering clinical diagnostics tests. The expanded laboratory will allow Karrington to focus on the continued growth of the lab, develop new and improved molecular diagnostic testing and laboratory processes, and expand its testing menu using its minimally invasive phlebotomy technology.
“At the onset of the pandemic Matrix swiftly pivoted and established new service lines, including a clinical laboratory, to deliver safe and expedient diagnostic testing services to our clients. We are incredibly proud of the work the laboratory team accomplished,” said Catherine J. Tabaka, Matrix Chief Executive Officer. “The healthcare industry continues to rapidly evolve, shifting client expectations and creating new competitive opportunities. Going forward, on behalf of its clients, Matrix will dedicate resources to strengthen its capabilities to deliver on our ambition to improve the health and life of those who need it most by bringing health and care directly to them in-home .”
Dr. Henry Bell will continue to lead Karrington in the role of Medical Director with a focus on bringing the medical community unique testing capabilities. Mark Parks will serve as the Chief Visionary Officer, bringing vast experience in the logistics industry and a goal of streamlining Karrington’s operations while meeting client needs and timelines.
“We are very excited to build on our more than twenty years of experience with expanded clinical diagnostic tests in the newly acquired CLIA-certified and CAP-accredited laboratory,” said Mark Parks, Karrington Chief Visionary Officer. “The newly expanded leadership team will keep our core operating principle: early detection – better health at the center of all we do. We will continue to provide the high-quality service we always have while growing our business with additional testing services.”
About Matrix Medical Network
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live for more than 20 years. The organization’s network of approximately 4,000 clinicians meets individuals wherever they are, to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Matrix Announces Sale of Decentralized Clinical Trials Service Line to EmVenio Research
Matrix Medical Network Announces Sale of Decentralized Clinical Trials Service Line to Emvenio Research
SCOTTSDALE, Ariz. and DURHAM, N.C., Aug. 8, 2022 /PRNewswire/ — Matrix Medical Network® (Matrix) and Emvenio Research® (Emvenio) today announced the sale of the Matrix Clinical Trials service line to Emvenio, a leading decentralized clinical trials (DCT) company. The transaction will provide Emvenio with proven DCT capabilities, while allowing Matrix to focus on improving the health and wellness of health plan members, and keeping America’s workers productive and safe, through its design of custom and flexible clinical solutions. Post transaction, Emvenio will deploy additional resources, technology, and capital to continue to grow and scale its clinical trials services both domestically and internationally, making clinical research more accessible, equitable, and effective.
“At the onset of the pandemic Matrix mobilized quickly to provide decentralized clinical trial solutions in support of vaccine and therapy development for COVID-19. We leveraged our skilled clinicians, Mobile Health Clinics, and experienced leaders to adapt traditional clinical trials protocols to better reach and recruit diverse, underserved, and high-risk patients,” said Catherine J. Tabaka, Matrix Chief Executive Officer. “We are incredibly proud of the remarkable work the Matrix Clinical Trials team started during the pandemic and continued to expand upon. I am excited about this transition and look forward to watching the leaders and employees of Emvenio continue to develop and deliver decentralized clinical trial solutions that best serve those patients who most need access to new treatments.”
“The leaders of Matrix Clinical Trials showed leadership, agility, creativity, and perseverance in building a decentralized clinical trial organization from the ground up,” said Keith Henthorne, Emvenio Chief Executive Officer. “I look forward to working closely with these leaders in order to build upon this solid foundation established by Matrix and to continue making clinical trials more accessible to diverse populations throughout the world. To ensure continued access to clinical trials for the patients who need it most, many Matrix employees and leaders will be a part of the Emvenio team going forward. I am proud to be working alongside strong leaders like Dr. Daniel Castillo and Thad Wolfram, amongst others, and look forward to growing the company with them.”
About Matrix Medical Network
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. The organization’s network of approximately 4,000 clinicians meets individuals wherever they are, to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
Matrix offers customizable solutions across distinct lines of business via in-home visits, telehealth, on-site support at medical facilities and businesses, and Mobile Health Clinics.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Catherine J. Tabaka Named CEO of Matrix Medical Network
Catherine J. Tabaka Named CEO of Matrix Medical Network
SCOTTSDALE, AZ, July 19, 2022 — Matrix Medical Network® (Matrix) today announced the appointment of Catherine J. Tabaka as Chief Executive Officer (CEO). Ms. Tabaka joined Matrix in 2021 and has served as interim CEO of the company since February of this year. For more than 20 years, Matrix has met individuals where they live and work to assess health and safety, identify and close care gaps, and offer life-changing services that empower them to better manage their own health.
Ms. Tabaka joined Matrix in June 2021 as Chief Operating Officer, bringing nearly 30 years of experience in driving commercial excellence, leading change, and executing exceptional organizational management. While serving as Chief Operating Officer, Ms. Tabaka provided strong leadership and direction that evolved Matrix’s way of operating, reinforced Matrix’s mission, and laid the groundwork for “One Matrix” culture.
After conducting an external search for a CEO the Matrix Board of Directors concluded that Ms. Tabaka is the best candidate to lead Matrix’s next chapter and the Board is confident that she will deliver on Matrix’s mission to positively impact the health and wellness of as many people as possible.
“Catherine is an accomplished healthcare executive with deep experience in driving operational, commercial, and financial performance,” said Brian Morfitt, Matrix Chairman of the Board. “She has done an outstanding job partnering across Matrix to navigate leadership transitions while instilling confidence and advancing the business forward with certainty. We look forward to Catherine’s leadership as Matrix enters its next stage of growth.”
Prior to joining Matrix, Ms. Tabaka was the President and CEO of Sodexo Healthcare in North America, the largest business unit for Sodexo worldwide. She also held global portfolio and commercial leadership roles at Hill-Rom Holdings, Inc., a leading global medical technology company, and at General Electric Corporation, where she spent two decades in their financial services and healthcare divisions in North and South America, Western and Eastern Europe, the Middle East, and Asia.
“It is an honor to be named CEO of an organization with such incredible potential. Our talented Matrix team will continue to progress, delivering on our mission to positively impact as many lives as we can, providing high-quality healthcare services, and improving the health of the patients and communities we serve,” said Ms. Tabaka. “Together, we will redefine operational excellence, accelerate growth, and nurture a diversified portfolio of offerings, all while continuing to provide expert care to all of the individuals and customers we serve.”
About Matrix Medical Network
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. The organization’s network of approximately 4,000 clinicians meets individuals wherever they are, to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
Matrix, in partnership with its expert clinical advisory panel, offers customizable solutions across distinct lines of business via in-home visits, telehealth, on-site support at medical facilities and businesses, and mobile health clinics.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Thermo Fisher Scientific Enhances Clinical Research Solutions in Collaboration with Matrix Clinical Trials
Thermo Fisher Scientific Enhances Clinical Research Solutions in Collaboration with Matrix Clinical Trials
Mobile research – sites an innovative decentralized trial solution – ease barriers to patient participation, improve trial enrollment
WILMINGTON, N.C., April 19, 2022 – The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, and Matrix Clinical Trials, a Matrix Medical Network offering, are collaborating to bring clinical trials to patients with an innovative decentralized clinical trial (DCT) solution. The business is deploying state-of-the-art Matrix mobile research sites and expert clinical staff across the U.S. to help identify, recruit and retain trial participants, while ensuring a positive patient experience. At the same time, the two companies are exploring opportunities to expand the collaboration to additional geographies.
Thermo Fisher’s clinical research business is the only clinical research organization (CRO) to use Matrix’s virtual principal investigator network coupled with mobile sites as a stand-alone transportable clinical trial operation. The collaboration demonstrates Thermo Fisher’s continuing commitment to advance decentralized trial solutions for customers and patients.
“We are proud to be a source for one of the latest clinical innovations to enhance patient-centric trial participation,” said Tim Rich, vice president, digital and decentralized solutions, clinical research, Thermo Fisher. “Mobile sites are a key component of our sought-after portfolio of hybrid and decentralized clinical trial capabilities. With Matrix’s experienced teams of clinicians and ready-to-deploy mobile sites, we are able to reach a broader range of participants, including in previously under-represented and under-served communities, without requiring them to travel to traditional investigator sites far from their homes.”
To view a video of Tim Rich commenting on the collaboration, visit mobile research sites.
Thermo Fisher’s clinical research business provides flexible decentralized trial solutions developed across multiple therapeutic areas. The goal is to increase patient diversity and access, and to improve the patient experience, resulting in time efficiencies and data quality enhancements that can help speed development timelines. These services reduce the burden for patients to participate in clinical trials, while providing customers with greater geographic reach through reduced reliance on brick-and-mortar site locations, more timely access to data, improved quality and consistency, and better patient engagement.
“Matrix is very excited to partner with such an innovative CRO in the decentralized clinical trial space,” said Thad Wolfram, president of Matrix Clinical Trials. “We have been enabling decentralized clinical trials and working together since the beginning of the pandemic, using our mobile sites as a critical component to diversifying clinical trial participant populations. As we’ve seen over the last year, these innovative offerings are providing a growing benefit across varying therapeutic areas to reach underserved and geographically diverse trial populations. Our novel collaboration with Thermo Fisher strongly aligns with both organizations’ vision of advancing life-saving clinical research and improving health outcomes for study participants.”
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Matrix Clinical Solutions to Provide On-Site Clinical Support and Point-of-Care COVID-19 Testing for Dallas Open Athletes, Coaches, and Support Staff
Matrix Clinical Solutions to Provide On-Site Clinical Support and Point-of-Care COVID-19 Testing for Dallas Open Athletes, Coaches, and Support Staff
Matrix Clinicians will Administer Rapid Antigen Tests Prior to the Event
SCOTTSDALE, Ariz., February 3, 2022 — Matrix Clinical Solutions, a Matrix Medical Network® (Matrix) business, will provide on-site rapid antigen testing and clinical support for athletes, coaches, and support staff as they arrive at the Dallas Open. Everyone will be tested prior to the tournament starting, and anyone who is unvaccinated will be tested every 48 hours while on-site as required by the Association of Tennis Professionals. With a nationwide network of approximately 5,000 clinicians and robust experience with COVID-19 testing, vaccination, and treatment in a variety of settings and geographies, Matrix was able to quickly activate to support the Dallas Open.
“Matrix has worked since the beginning of the pandemic to develop and implement rapid and scalable strategies and solutions to mitigate the risk of COVID-19,” said Matrix Clinical Solutions Chief Medical Officer Dan Meltzer, M.D. “We are pleased to work closely with the Dallas Open to ensure the event runs smoothly and the athletes and staff feel safe and comfortable.”
Matrix is uniquely positioned to support COVID-19 testing with a range of services that can be adapted and quickly deployed to meet partners’ needs by:
- Assessing the unique needs of our partners and designing customized testing strategies
- Mobilizing expert clinicians on-site for convenient and timely access to testing
- Providing education and multilingual staff to address critical questions and alleviate concerns
- Providing clinical consultations for individuals that test positive for COVID-19 and assisting them with managing their specific situation
- Activating and implementing quickly to support a variety of situations and needs
About Matrix Clinical Solutions
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. The organization’s network of approximately 5,000 clinicians meets individuals wherever they are to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
Matrix Clinical Solutions helps America’s communities and workers stay healthy while maintaining businesses’ productivity and continuity through tailored health solutions. Our all-in-one worksite health offering delivers flexible on-site, virtual, and mobile employer health services including occupational, primary, preventative, urgent, and episodic care with its own fully integrated lab.
For more information, visit https://mmnprd.wpengine.com/clinical-solutions/.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
About GF Sports & Entertainment
GF Sports & Entertainment is a global events and operations company that elevates the experience of live sports, entertainment and interactive events. The company owns two of the ATP Tour’s longest running American tennis tournaments, the Dallas Open and the Truist Atlanta Open, as well as the National Lacrosse League New York Riptide. In partnership with the American Kennel Club (AKC), the leading registry and governing body of canine events in the United States, they operate the AKC Meet the Breeds® touring show. GF Sports & Entertainment also incubates new and emerging sport concepts, this includes Wolf Pack Ninjas, which operates ninja-focused events globally.
GF Sports & Entertainment was founded in July 2015 by New York-based private equity firm GF Capital. For additional information, please visit www.gfsportsandentertainment.com.
About The Dallas Open
The Dallas Open is an ATP Tour 250 men’s tournament that will make its debut in Dallas on February 6 – 13, 2022 at the Styslinger/Altec Tennis Complex at SMU. It will be the only ATP Tour indoor championship in the United States, and features men’s top world tennis players in singles and doubles competition. The tournament, previously held as the New York Open, is one of the longest-running American tournaments on the ATP Tour. Its rich history features some of the top names in tennis, including legends John McEnroe, Pete Sampras, Andre Agassi, Andy Roddick, Michael Chang, and Andy Murray, and a current generation of stars like Kei Nishikori, Milos Raonic, and Reilly Opelka.
Matrix Clinical Trials and Cambridge Healthtech Institute to Provide On-Site COVID-19 Testing at SCOPE Meeting
Matrix Clinical Trials and Cambridge Healthtech Institute to Provide On-Site COVID-19 Testing at SCOPE Meeting
Health and Safety Protocols Allow Attendees, Exhibitors, Speakers, and Staff to Attend Meeting In-Person
SCOTTSDALE, Ariz. and Needham, Mass., January 27, 2022 — Matrix Clinical Trials, a Matrix Medical Network® (Matrix) business, and Cambridge Healthtech Institute (CHI) will be providing on-site COVID-19 testing to support attendees, exhibitors, speakers, and staff attending the 13th annual SCOPE: Summit for Clinical Ops Executives meeting in Orlando, Florida February 7-10. CHI instituted mandatory health and safety protocols, including a requirement of a negative COVID-19 test, to ensure maximum safety at the event. Matrix will deploy a state-of-the-art Mobile Health Clinic and expert clinical staff to conduct Rapid Antigen Tests and provide results within 15-20 minutes.
“With capabilities in decentralized clinical trials, our fleet of Mobile Health Clinics, and a network of approximately 5,000 clinicians and virtual principal investigators, Matrix has enabled clinical trials for COVID-19 vaccine and treatment, COVID-19 testing, vaccination and treatment, and workplace safety solutions,” said Matrix Clinical Trials President Thad Wolfram. “Our team of clinicians is excited to provide peace of mind to on-site attendees, exhibitors, speakers, and staff at SCOPE.”
“As we return to in-person events, CHI is pleased to have partnered with Matrix Clinical Trials as they assist in the COVID testing of our staff, exhibitors, and attendees at this year’s SCOPE Summit event,” said Angela Parsons, Vice President of Business Development, Cambridge Innovation Institute.
The Mobile Health Clinic will be parked on The Terraces in Rosen Shingle Creek in Orlando:
- Monday, February 7 | 9a.m.-7:15p.m.
- Tuesday, February 8 | 7:15a.m.-5:45p.m.
- Wednesday, February 9 | 7:15a.m.-4p.m.
About Matrix Clinical Trials
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. Matrix Clinical Trials leverages their network of approximately 5,000 skilled clinicians, virtual Principal Investigators, and integrated laboratory services contributing to providing robust care services via home visits, on-site support, virtual visits, and mobile sites.
Matrix Clinical Trials provides rapid and scalable decentralized trial solutions to reach hard to recruit and retain clinical trial participants across varying geographies and ethnicities, accelerate clinical trials, and maintain stringent quality and compliance. In the past year Matrix clinicians have conducted more than 11,800 participant visits, partnered with more than 40 trial sites, and supported the rapid development of COVID-19 vaccines and treatments.
For more information, visit https://mmnprd.wpengine.com/clinical-trials/.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, World Pharma Week, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT World, Clinical Research News and Diagnostics World. For more information visit healthtech.com
Crossover Health and Matrix Announce Joint Primary Care and Occupational Health Offering for Employers
Crossover Health and Matrix Clinical Solutions Announce Joint Primary Care and Occupational Health Offering for Employers
SAN CLEMENTE, CA and SCOTTSDALE, AZ, January 20, 2022 — Crossover Health, a leader in delivering value-based hybrid care, and Matrix Clinical Solutions, a Matrix Medical Network ® company and provider of workers compensation health services, announced today at the 2022 Onsite Employee Health Clinics Summit in Scottsdale, Arizona, that they will offer a joint primary care and occupational health solution. The new-to-market offering will combine Crossover’s Primary Health care model, inclusive of primary care, physical medicine, mental health, coaching and care navigation, with Matrix’s custom workplace health solutions, such as onsite occupational health, workplace certification and vaccine deployment and testing, providing employers with a comprehensive health, safety and well-being strategy.
Employer investment in both primary care and occupational health is growing exponentially, in large part because of the evolving workplace health and safety considerations of the pandemic-era. According to a study conducted by Mercer and the National Association of Worksite Health Centers, employers are embracing more expansive health services. Similarly, employers are making major investments in the Occupational Health & Workplace Safety Services industry, contributing to an estimated market size of $7.1b by 2022.
“The pandemic has emphasized an existing demand for employer-sponsored healthcare solutions, as well as workplace health and safety measures, with many employers seeking something more comprehensive and long-term than current offerings,” explained Stephen Ezeji-Okoye, MD Chief Medical Officer, Crossover Health. “Collaborating with Matrix will enable Crossover to offer to employers a broader range of services, streamlining the care experience and delivering meaningful results.”
Matrix Chief Medical Officer and Group President, Daniel Castillo, M.D., M.B.A., added, “We look forward to working alongside Crossover starting with our existing episodic health solutions and exploring the potential to build out comprehensive and convenient solutions for employers who are taking workplace health and safety to the next level. Our combined national footprint coupled with our commitment to improving clinical outcomes and lowering the total cost of care will enable us to create a new standard for workplace health through this joint offering.”
Crossover and Matrix each operate in all 50 states, and combined have approximately 250 physical locations and nearly 6,000 health care providers and staff. The companies share a dedication to the role of foundational primary care and preventative health, and have deep roots in employer-sponsored healthcare. The collaborative solutions are anticipated to be offered later this year.
For more information, visit crossoverhealth.com and matrixmedicalnetwork.com.
About Crossover Health
Crossover Health is a leader in delivering value-based hybrid care. The company’s national medical group delivers – at scale – Primary Health, a proven care model driven by an interdisciplinary team inclusive of primary care, physical medicine, mental health, health coaching and care navigation. With a focus on wellbeing and prevention that extends beyond traditional sick care, Crossover builds trusted relationships with its members and flexibly surrounds them with care – in-person, online, and anytime – based on the member preference. Combining a sophisticated approach to data analytics that incorporate social determinants of health, Crossover delivers concrete results and measurable value for employers, payers and most importantly, members. Together we are building health as it should be and engaging a community of members to live their best health. To learn more, visit crossoverhealth.com or follow us on social media @crossoverhealth.
About Matrix Clinical Solutions
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. The organization’s network of approximately 5,000 clinicians meets individuals wherever they are to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
Matrix Clinical Solutions helps America’s communities and workers stay healthy while maintaining businesses’ productivity and continuity through tailored health solutions. Our all-in-one worksite health offering delivers flexible on-site, virtual, and mobile employer health services, including occupational, primary, preventative, urgent, and episodic care, with fully integrated labs.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Matrix Medical Network Appoints Tom Catchings as Chief Information Officer
Matrix Medical Network Appoints Tom Catchings as Chief Information Officer
SCOTTSDALE, Ariz., December 22, 2021 — Matrix Medical Network® (Matrix) today announced the appointment of Tom Catchings as Chief Information Officer. For more than 20 years, Matrix has met individuals where they live and work to assess health and safety, identify and close care gaps, and offer life-changing services that empower them to better manage their own health. Early in 2021 Matrix announced the evolution of its business into four distinct lines of business: Matrix Clinical Care, Matrix Clinical Solutions, Matrix Clinical Trials, and Matrix Clinical Labs. As our business continues to evolve, Tom will help to ensure we are well prepared for growth, innovation, and diversification.
As a transformative technology leader with companies across multiple industries, Tom brings more than 25 years of experience in business and technology, managing all aspects of IT, including Enterprise Systems, DevOps, Network Operations, Data Management and Strategy. His experience developing, leading, and leveraging technology as it relates to growth and profitability uniquely positions him to help guide Matrix.
Tom joins Matrix from naviHealth, where he served as Chief Technology Officer, leading their IT team with a focus on driving security and scalability in the company’s internal infrastructure and powering customer-facing digital health care transformation. Prior to joining naviHealth, Tom served as Senior Vice President of Technology and CIO of WageWorks Inc., a leading SaaS provider of consumer-directed benefits, servicing over seven million employees across 80,000 business clients.
“Matrix identified new and different healthcare needs at the beginning of the pandemic and rapidly deployed our approximately 5,000 expert clinicians and state-of-the-art Mobile Health Clinics to help keep the employee groups and communities we serve safe,” said Matrix Chairman and Chief Executive Officer Keith Henthorne. “Tom’s expertise will help us to ensure our IT infrastructure best supports Matrix and sets us up for continued sustainable growth.”
“This is an amazing time to be joining Matrix and I very much look forward to advancing the organization with new and different technologies to better serve our members, patients, and communities,” said Matrix Chief Information Officer, Tom Catchings.
About Matrix Medical Network
- Matrix Clinical Care helps seniors and other at-risk individuals enjoy a better quality of care, experience better health outcomes, and identify chronic conditions that may otherwise go undiagnosed.
- Matrix Clinical Solutions Matrix Clinical Solutions helps keep workers healthy and businesses run productively with its tailored, flexible onsite and mobile employer health services, including occupational, primary, preventative, urgent and episodic care as well as a fully integrated lab that uniquely focusses on total worker health.
- Matrix Clinical Trials provides rapid and scalable decentralized trial solutions to help organizations better reach and recruit diverse, underserved, and high-risk communities. Matrix’s network of skilled clinicians and virtual Principal Investigators enable us to provide robust care services via home visits, on-site support at medical facilities, virtual visits, and mobile sites.
- Matrix Clinical Labs is a CLIA-certified and CAP-accredited laboratory that provides state-of-the-art diagnostic services and clinical testing support to industry and its other lines of business. For more information, visit matrixmedicalnetwork.com.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.
Matrix Clinical Solutions Partners with the Colorado Department of Public Health and Environment to Provide Monoclonal Antibody Therapy to COVID-19 Patients Across the State
Matrix Clinical Solutions Partners with the Colorado Department of Public Health and Environment to Provide Monoclonal Antibody Therapy to COVID-19 Patients Across the State
SCOTTSDALE, Ariz., December 7, 2021 — Matrix Clinical Solutions, a Matrix Medical Network® (Matrix) business, and the Colorado Department of Public Health and Environment (CDPHE) are working together to provide wider access to monoclonal antibody therapy for the treatment of COVID-19 across the state. With a nationwide network of approximately 5,000 clinicians and a fleet of state-of-the-art Mobile Health Clinics, Matrix was able to quickly bring this important treatment into the community.
Matrix and the CDPHE currently have six Mobile Health Clinics active across the state and plan to increase this number in the coming weeks. Access to monoclonal antibody treatment in Colorado is available if you have tested positive for COVID-19 and meet the requirements. Individuals seeking treatment can visit https://www.comassvax.org/ or call: 1-877- CO VAX CO line.
“Matrix has worked since the beginning of the pandemic to develop and implement rapid and scalable strategies and solutions to mitigate the risk of COVID-19 through our team of clinicians and Mobile Health Clinics,” said Matrix Clinical Solutions Chief Medical Officer Dan Meltzer, M.D. “We are proud to partner with the Colorado Department of Public Health and Environment to bring monoclonal antibody therapy and related care to Coloradans that have tested positive for COVID-19 in harder to reach areas of the state. This work is critical to help prevent severe illness and reduce the hospitalizations that are placing a significant burden on the healthcare system.”
Matrix is uniquely positioned to support monoclonal antibody therapy administration with a range of services that can be adapted and quickly deployed to meet partners’ needs by:
- Activating quickly to support emergent situations and needs
- Navigating state regulations and supporting the process of securing treatments
- Mobilizing expert clinicians on-site for convenient and timely access to treatments
- Providing education and multilingual staff to address critical questions and alleviate concerns
About Matrix Clinical Solutions
Matrix Medical Network has provided expert care and health services to millions of at-risk individuals where they live and work for more than 20 years. The organization’s network of approximately 5,000 clinicians meets individuals wherever they are to assess their health and safety, identify and close care gaps, and offer life-changing services that activate them to manage their own health.
Matrix Clinical Solutions helps America’s communities and workers stay healthy while maintaining businesses’ productivity and continuity through tailored health solutions. Our all-in-one worksite health offering delivers flexible on-site, virtual, and mobile employer health services including occupational, primary, preventative, urgent, and episodic care with its own fully integrated lab.
For more information, visit https://mmnprd.wpengine.com/clinical-solutions/.
*Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.